Inflammatory arthritis is a major cause of disability in the elderly. This condition causes joint
pain, loss of function, and deterioration of quality of life, mainly due to osteoarthritis (OA) and …

Rheumatoid arthritis (RA) is a heterogeneous autoimmune inflammatory disorder defined by
the damage to the bone and cartilage in the synovium, which causes joint impairment and …

Stimuli‐responsive nanoparticles have the potential to improve the delivery of therapeutics
to a specific cell or region within the body. There are many stimuli that have shown potential …

Local delivery of therapeutics for the treatment of inflammatory arthritis (IA) is limited by short
intra-articular half-lives. Since IA severity often fluctuates over time, a local drug delivery …

Increasing understanding of the pathogenesis of rheumatoid arthritis (RA) has remarkably
promoted the development of effective therapeutic regimens of RA. Nevertheless, the …

Complex three-dimensional (3D) pore geometries, useful for tissue engineering scaffolds,
can be fabricated via photo-crosslinking of resorbable poly (propylene fumarate)(PPF) …

Drug delivery for osteoarthritis (OA) treatment is a continuous challenge because of their
poor bioavailability and rapid clearance in joints. Intra-articular (IA) drug delivery is a …

3D/4D printing is enabling transformative advances in device manufacturing and medicine
but remains limited by the lack of printable resorbable materials with advanced properties …

Drugs administered through conventional formulations are devoid of targeting and often
spread to various undesired sites, leading to sub-lethal concentrations at the site of action …

Inflammatory processes are increasingly being identified at the core of many different
disease states (eg heart disease, cancer, diabetes). As such, anti-inflammatory strategies …